Search results for "Sparta"

showing 10 items of 301 documents

The NMDA receptor complex: a promising target for novel antiepileptic strategies.

2001

Antiepileptic drugs (AEDs) cover a broad spectrum of pathological conditions ranging from seizures following congenital or acquired brain disorders to behavioural and psychiatric disorders and recently neuropathic pain. The need for novel antiepileptics raises from the expanding field of indications as well as from the fact, that special seizure types are refractory to common AEDs. In addition, many of the conventional antiepileptic drugs exhibit an unfavourable side-effect profile. Since there is growing evidence, that NMDA receptor activation might play a crucial role in epilepsy, NMDA receptor antagonists have become compounds of interest in preventing and treating seizures. This review …

N-Methylaspartatemedicine.medical_treatmentPharmacologyBiochemistryReceptors N-Methyl-D-AspartateFelbamatechemistry.chemical_compoundEpilepsyDrug DiscoveryIfenprodilmedicineAnimalsHumansRemacemidePharmacologyEpilepsybusiness.industryOrganic ChemistryMemantinemedicine.diseaseDizocilpineAnticonvulsantchemistryMolecular MedicineAnticonvulsantsbusinessEliprodilmedicine.drugCurrent medicinal chemistry
researchProduct

Action of anticonvulsants on hippocampal slices in Mg-free medium

1989

The effects of six prototype anticonvulsant drugs were investigated on epileptiform field potential discharges evoked in hippocampal slices of rats by removing magnesium ions from the perfusion fluid in order to reveal a possible interaction with N-methyl-D-aspartate (NMDA) receptor activation. All drugs reduced the multiple discharges with the following order of potency: midazolam greater than carbamazepine = phenytoin = phenobarbital greater than ethosuximide = valproate. They had a stronger depressant effect on the later population spikes but none of them abolished the epileptiform discharge. These effects can be explained by known mechanisms of action of the anticonvulsants tested and l…

N-Methylaspartatemedicine.medical_treatmentPopulationPyramidal TractsIn Vitro TechniquesPharmacologyHippocampusReceptors N-Methyl-D-AspartatemedicineAnimalsMagnesiumeducationMagnesium ionPharmacologyAspartic Acideducation.field_of_studyEpilepsyDose-Response Relationship DrugChemistryElectroencephalographyRats Inbred StrainsGeneral MedicineCarbamazepineElectric StimulationRatsReceptors NeurotransmitterPerfusionEthosuximideAnticonvulsantnervous systemMechanism of actionNMDA receptorAnticonvulsantsPhenobarbitalmedicine.symptommedicine.drugNaunyn-Schmiedeberg's Archives of Pharmacology
researchProduct

The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

2020

Background & Aims NAFLD is a growing health concern. The aim of the Fatty Liver Assessment in Germany (FLAG) study was to assess disease burden and provide data on the standard of care from secondary care. Methods The FLAG study is an observational real-world study in patients with NAFLD enrolled at 13 centres across Germany. Severity of disease was assessed by non-invasive surrogate scores and data recorded at baseline and 12 months. Results In this study, 507 patients (mean age 53 years; 47% women) were enrolled. According to fibrosis-4 index, 64%, 26%, and 10% of the patients had no significant fibrosis, indeterminate stage, and advanced fibrosis, respectively. Patients with advanced fib…

NAFLD non-alcoholic fatty liver diseasemedicine.medical_specialtyBMI body mass indexNASH non-alcoholic steatohepatitisLiver fibrosisLSM liver stiffness measurementAST aspartate aminotransferaseLiver diseaseFLAG Fatty Liver Assessment in GermanyNAFLDALT alanine aminotransferaseInternal medicineAPRI aspartate-aminotransferase-to-platelet ratio indexInternal MedicineNAFL non-alcoholic fatty liverImmunology and AllergyMedicineddc:610Co-morbiditieslcsh:RC799-869FIB-4 fibrosis-4Disease burdenHepatologyFAST FibroScan-ASTGGT gamma-glutamyltransferasebusiness.industryFatty liverNASHGastroenterologyReal worldGLP-1 glucagon-like peptide-1T2DM type 2 diabetes mellitusCVE cardiovascular eventmedicine.diseaseMetabolic syndromeCohortlcsh:Diseases of the digestive system. GastroenterologyCAP controlled attenuation parameterSteatohepatitisMetabolic syndromebusinessBody mass indexResearch ArticleCohort studyJHEP Reports
researchProduct

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

2021

Background & Aims Progressive fibrosis has been identified as the major predictor of mortality in patients with non-alcoholic fatty liver disease (NAFLD). Several biomarkers are currently being evaluated for their ability to substitute the liver biopsy as the reference standard. Recent clinical studies in NAFLD/NASH patients support the utility of PRO-C3, a marker of type III collagen formation, as a marker for the degree of fibrosis, disease activity, and effect of treatment. Here we establish the healthy reference range, optimal sample handling conditions for both short- and long-term serum storage, and robustness for the PRO-C3 assay. Methods PRO-C3 was measured in 269 healthy volunteers…

NASH-CRN NASH Clinical Research NetworkBiopsyDiseaseAST aspartate aminotransferaseRC799-869Ethnic groupsGastroenterologyNIMBLE Non-Invasive Biomarkers of Metabolic Liver Disease (consortium)FibrosisImmunology and AllergyBody mass indexmedicine.diagnostic_testFatty liverNAS NAFLD Activity ScoreGastroenterologyDiseases of the digestive system. GastroenterologyHospitalsNPV negative predictive valueLiver biopsyBiomarker (medicine)Research Articlemedicine.medical_specialtyNAFLD non-alcoholic fatty liver diseaseADAM A Disintegrin and MetalloproteasesNASH non-alcoholic steatohepatitisReference rangeReference valuesAUROC area under the receiver operating characteristics curveInternal medicineALT alanine aminotransferaseBiopsyInternal MedicinemedicineHumansFIB-4 fibrosis-4Healthy volunteersHepatologyALP alkaline phosphatasebusiness.industryCLSI Clinical and Laboratory Standards InstituteT2DM type 2 diabetes mellitusELF™ test Enhanced Liver Fibrosis testmedicine.diseaseLITMUS Liver Investigation: Testing Marker Utility in Steatohepatitis (consortium)Collagen type IIIFibrosisPPV positive predictive valueReference standardsbusinessBody mass indexBiomarkersNon-alcoholic fatty liver disease
researchProduct

Production of polymeric micro- and nanostructures with tunable properties as pharmaceutical delivery systems

2020

Abstract The production of novel graft copolymers based on poly-e-caprolactone (PCL) and polyaspartamide are useful to realize structures for potential biomedical applications. Here, the synthesis of pegylated PCL/polyhydroxyethyl aspartamide (PHEA) graft copolymers (PHEA-g-SUCC-PCL-g-PEG) with tunable composition, was achieved by followpling a synthetic strategy that involved first the grafting of preformed PCL on PHEA backbone, then polyethylen glycol (PEG), by using 1,1′-carbonyldiimidazole (CDI) to speed up the condensation reaction. Graft copolymers with a Derivatization Degree (DD) in PCL ranging between 1.1 and 4.4 mol% were obtained, and processable with different technologies for t…

NanostructureMaterials sciencePolymers and PlasticsMicrofluidicsNanoparticlemacromolecular substances02 engineering and technology010402 general chemistry01 natural sciencesPEG ratioMaterials ChemistryCopolymerOrganic Chemistrytechnology industry and agricultureαβ-poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA)equipment and suppliesmusculoskeletal system021001 nanoscience & nanotechnologyCondensation reactionGrafting0104 chemical sciencesGraft copolymerChemical engineeringMicrofluidicMicroparticlePoly-ε-caprolactone (PCL)Settore CHIM/09 - Farmaceutico Tecnologico ApplicativoNanoparticles0210 nano-technologyNanoprecipitation
researchProduct

Changes in NMDA-receptor function in the first week following laser-induced lesions in rat visual cortex.

2011

Focal brain injuries are accompanied by processes of functional reorganization that partially compensate the functional loss. In a previous study, extracellular recordings at the border of a laser-induced lesion in the visual cortex of rats showed an enhanced synaptic plasticity, which was mediated by the activity of NR2B-contaning NMDA-receptors (NMDARs) shedding light on the potential cellular mechanisms underlying this reorganization. Given the potentially important contribution of NMDARs in processes of functional reorganization, in the present study, we used the same lesion model to further investigate lesion-induced changes in function and localization of NMDARs in the vicinity of the…

Neuronal Plasticitymusculoskeletal neural and ocular physiologyCognitive NeuroscienceLasersBiologyReceptors N-Methyl-D-AspartateRatsLesionCellular and Molecular NeuroscienceGlutamatergicmedicine.anatomical_structureVisual cortexnervous systemCerebral cortexSynaptic plasticityNeuroplasticitymedicineNMDA receptorAnimalsmedicine.symptomRats WistarReceptorNeuroscienceVisual CortexCerebral cortex (New York, N.Y. : 1991)
researchProduct

The role of N-methyl-D-asparate receptors in neurogenesis.

2006

The dentate gyrus continues to incorporate granule neurons during adulthood. Among the factors that we know modulate adult neurogenesis in the dentate gyrus, one of the first studied was the influence of excitatory amino-acids. These neurotransmitters, acting through NMDA receptors, are able to modulate both the proliferation of progenitor cells as well as the rate of neurogenesis in the adult dentate gyrus. However, the mechanisms by which these processes are influenced are not clearly known. Although there is no anatomical evidence of NMDA receptor expression in adult hippocampal progenitor cells or differentiating granule neurons, electrophysiological data and in vitro studies suggest th…

NeuronsNeuronal PlasticityNeuriteCognitive NeuroscienceDentate gyrusStem CellsNeurogenesisGlutamic AcidCell DifferentiationHippocampal formationBiologyReceptors N-Methyl-D-Aspartatenervous systemDentate GyrusNMDA receptorAnimalsHumansProgenitor cellReceptorLong-term depressionNeuroscienceCell ProliferationHippocampus
researchProduct

The neurochemistry of autism

2020

Autism spectrum disorder (ASD) refers to complex neurobehavioral and neurodevelopmental conditions characterized by impaired social interaction and communication, restricted and repetitive patterns of behavior or interests, and altered sensory processing. Environmental, immunological, genetic, and epigenetic factors are implicated in the pathophysiology of autism and provoke the occurrence of neuroanatomical and neurochemical events relatively early in the development of the central nervous system. Many neurochemical pathways are involved in determining ASD; however, how these complex networks interact and cause the onset of the core symptoms of autism remains unclear. Further studies on ne…

OpinionSerotoninN-acetyl aspartateSensory processingmedicine.medical_treatmentDopamineOxytocinlcsh:RC321-57103 medical and health sciencesTherapeutic approachGABA0302 clinical medicineNeurochemicalmental disordersmedicineNeurochemistryAutism spectrum disorderlcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biologyEndogenous opioidMelatonin0303 health sciencesbusiness.industryGeneral NeuroscienceGlutamate receptorNeurochemistrymedicine.diseaseAcetylcholineAutism spectrum disorderAutismGlutamatebusinessNeuroscience030217 neurology & neurosurgery
researchProduct

FUNCTIONALITATION OF HYDROPHOBIC SURFACES WITH A POLYASPARTAMIDE-BASED DERIVATIVE FOR BIOMEDICAL APPLICATION

2013

PLAPOLYASPARTAMIDE; PLA; THIOL-YNETHIOL-YNEPOLYASPARTAMIDEPOLYASPARTAMIDE PLA THIOL-YNE
researchProduct

NUOVI COPOLMERI BIOCOMPATIBILI A BASE DI POLI-IDROSSIETILASPARTAMMIDE PER IL NONVIRAL GENE DELIVERY

2012

POLI-IDROSSIETILASPARTAMMIDESettore CHIM/09 - Farmaceutico Tecnologico ApplicativoNONVIRAL GENE DELIVERY
researchProduct